Home › Funds › VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. › DGX
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. position in DGX
QUEST DIAGNOSTICS INC · Health Care
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. reported holding 193,776 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$45.2M, representing 0.34% of its reported portfolio and ranking #45 among its reported holdings. VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. has disclosed DGX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.'s DGX position evolved
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. first disclosed a stake in DGX in Q2 2024 at 356,390 shares (US$48.8M). The position peaked in Q4 2024 at 514,558 shares, worth US$77.6M. Across 10 filings, VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 193,776 shares valued at US$45.2M — a reduction of -49,131 shares quarter over quarter.. Notable position changes include a 31% increase in Q4 2024 (shares rose 12% over the following quarter), a 49% trim in Q4 2025 (shares rose 13% over the following quarter), a 46% increase in Q1 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 356.39K | $48.78M | New |
| Q3 2024 | 393.02K | $61.02M | Add |
| Q4 2024 | 514.56K | $77.63M | Add |
| Q1 2025 | 431.30K | $72.98M | Reduce |
| Q2 2025 | 408.20K | $73.32M | Reduce |
| Q3 2025 | 341.65K | $65.11M | Reduce |
| Q4 2025 | 175.15K | $30.39M | Reduce |
| Q1 2026 | 256.30K | $50.23M | Add |
| Q2 2026 | 242.91K | $51.48M | Reduce |
| Q3 2026 | 193.78K | $45.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.64M sh · $1.08B · Q3 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.93M sh · $449.89M · Q3 2026
- DAVIS SELECTED ADVISERS 1.33M sh · $308.97M · Q3 2026
- M&G Plc 770.10K sh · $179.43M · Q3 2026
More on VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.
FAQ
How long has VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. held DGX?
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. has disclosed DGX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.'s current position in DGX?
As of Q3 2026, VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. holds 193.78K shares of DGX (QUEST DIAGNOSTICS INC), valued at $45.16M, representing 0.34% of its reported portfolio and ranking #45.
Has VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. been buying or selling DGX?
In the latest 13F filing (Q3 2026), VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. reduced its position in DGX. The position peaked in Q4 2024 at 514.56K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.